Ovarian cancer has features that makes it well-suited for MAb adjuvant immunotherapy. Several of the MAbs used in clinical trials mediate cancer cell destruction by activation of complement (C). In this study, therefore, we examined the ability of ovarian-tumor cells to resist C attack. We found tha
β¦ LIBER β¦
Role of complement and complement regulatory proteins in glomerulonephritis
β Scribed by Quigg, Richard J.
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 773 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0344-4325
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Complement-regulatory proteins in ovaria
β
Line BjΓΈrge; Juha Hakulinen; Torsten WahlstrΓΆm; Roald Matre; Seppo Meri
π
Article
π
1997
π
John Wiley and Sons
π
French
β 727 KB
Complement factor H and related proteins
β
Peter F. Zipfel; Christine Skerka
π
Article
π
1994
π
Elsevier Science
π
English
β 695 KB
Expression of complement regulatory prot
β
D. J. V. Bridgewater; A. Mok; D. G. Matsell
π
Article
π
2000
π
Springer
π
English
β 268 KB
Controlling complement resistance in can
β
Federica Ziller; Paolo Macor; Roberta Bulla; Daniele Sblattero; Roberto Marzari;
π
Article
π
2005
π
John Wiley and Sons
π
English
β 258 KB
Expression of the complement-regulatory proteins (CRP) CD46, CD55 and CD59 represents a strategy used by tumor cells to evade complement-dependent cell cytoxicity stimulated by monoclonal antibodies. We have isolated two single-chain variable fragments (scFv) to CD55 and CD59 from a human phage-disp
Immune evasion of tumor cells using memb
β
Arko Gorter; Seppo Meri
π
Article
π
1999
π
Elsevier Science
π
English
β 207 KB
Streptococcal antibodies and complement
Streptococcal antibodies and complement components in tropical post-streptococcal glomerulonephritis
β
Grace Koshi; G. Sridharan; C.P. Thangavelu; J.C.M. Shastry
π
Article
π
1983
π
Elsevier Science
π
English
β 269 KB